THE ADDITION OF ANTI-ANGIOGENIC TYROSINE KINASE INHIBITORS TO CHEMOTHERAPY FOR ADVANCED NON-SMALL CELL LUNG CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS
Publication
, Conference
Li, BT; Hasovits, C; Lee, A; Li, AE; Khasraw, M; Marx, G; Pavlakis, N
Published in: JOURNAL OF THORACIC ONCOLOGY
November 1, 2013
Duke Scholars
Published In
JOURNAL OF THORACIC ONCOLOGY
EISSN
1556-1380
ISSN
1556-0864
Publication Date
November 1, 2013
Volume
8
Start / End Page
S608 / S608
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Li, B. T., Hasovits, C., Lee, A., Li, A. E., Khasraw, M., Marx, G., & Pavlakis, N. (2013). THE ADDITION OF ANTI-ANGIOGENIC TYROSINE KINASE INHIBITORS TO CHEMOTHERAPY FOR ADVANCED NON-SMALL CELL LUNG CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS. In JOURNAL OF THORACIC ONCOLOGY (Vol. 8, pp. S608–S608). LIPPINCOTT WILLIAMS & WILKINS.
Li, Bob T., Csilla Hasovits, Adrian Lee, Angela E. Li, Mustafa Khasraw, Gavin Marx, and Nick Pavlakis. “THE ADDITION OF ANTI-ANGIOGENIC TYROSINE KINASE INHIBITORS TO CHEMOTHERAPY FOR ADVANCED NON-SMALL CELL LUNG CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS.” In JOURNAL OF THORACIC ONCOLOGY, 8:S608–S608. LIPPINCOTT WILLIAMS & WILKINS, 2013.
Li BT, Hasovits C, Lee A, Li AE, Khasraw M, Marx G, et al. THE ADDITION OF ANTI-ANGIOGENIC TYROSINE KINASE INHIBITORS TO CHEMOTHERAPY FOR ADVANCED NON-SMALL CELL LUNG CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS. In: JOURNAL OF THORACIC ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS; 2013. p. S608–S608.
Li, Bob T., et al. “THE ADDITION OF ANTI-ANGIOGENIC TYROSINE KINASE INHIBITORS TO CHEMOTHERAPY FOR ADVANCED NON-SMALL CELL LUNG CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS.” JOURNAL OF THORACIC ONCOLOGY, vol. 8, LIPPINCOTT WILLIAMS & WILKINS, 2013, pp. S608–S608.
Li BT, Hasovits C, Lee A, Li AE, Khasraw M, Marx G, Pavlakis N. THE ADDITION OF ANTI-ANGIOGENIC TYROSINE KINASE INHIBITORS TO CHEMOTHERAPY FOR ADVANCED NON-SMALL CELL LUNG CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS. JOURNAL OF THORACIC ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS; 2013. p. S608–S608.
Published In
JOURNAL OF THORACIC ONCOLOGY
EISSN
1556-1380
ISSN
1556-0864
Publication Date
November 1, 2013
Volume
8
Start / End Page
S608 / S608
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology